Name | (2E)-N-(4,5-Dihydro-1,3-thiazol-2-yl)-3-(4-ethylphenyl)acrylamide |
---|---|
Synonyms |
(2E)-N-(4,5-Dihydro-1,3-thiazol-2-yl)-3-(4-ethylphenyl)acrylamide
2-Propenamide, N-(4,5-dihydro-2-thiazolyl)-3-(4-ethylphenyl)-, (2E)- Streptomyces metabolite 2880 II 2880-II |
Description | ML243 is a selective small-molecule inhibitor of breast cancer stem cells. ML243 has 32-fold greater selective inhibition in the breast CSC-like cell line HMLE_shECad than the control cell line HMLE_shGFP[1]. |
---|---|
Related Catalog | |
Target |
Breast CSCs[1] |
References |
Density | 1.2±0.1 g/cm3 |
---|---|
Molecular Formula | C14H16N2OS |
Molecular Weight | 260.355 |
Exact Mass | 260.098328 |
PSA | 70.25000 |
LogP | 2.65 |
Index of Refraction | 1.608 |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302 |
Precautionary Statements | P301 + P312 + P330 |
RIDADR | NONH for all modes of transport |
~40% 1426576-80-8 |
Literature: THE BROAD INSTITUTE, INC.; GERMAIN, Andrew; MUNOZ, Benito; LEWIS, Timothy, A.; TING, Amal; YOUNGSAYE, Willmen; NAG, Partha, P.; DOCKENDORFF, Christopher; FERNANDEZ, Cristina, Victoria; DONCKELE, Etienne; MORGAN, Barbara; SKODA, Erin, M.; SHU, Byubg-Chul Patent: WO2013/32907 A1, 2013 ; Location in patent: Page/Page column 54 ; |